Header Logo

Connection

Michael Jelinek to Poly(ADP-ribose) Polymerase Inhibitors

Back to Details
This is a "connection" page, showing publications Michael Jelinek has written about Poly(ADP-ribose) Polymerase Inhibitors.
Michael Jelinek
Connection Strength
0.755
Poly(ADP-ribose) Polymerase Inhibitors
  1. A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101. Oral Oncol. 2021 03; 114:105171.
    View in: PubMed
    Score: 0.755
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.